| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| KLS-2031 | KLS-2031 | Phase 2 Clinical | Kolon Life Science. Inc | Radiculopathy | Details |
| NGM-386 | NGM-386 | Phase 1 Clinical | Ngm Biopharmaceuticals Inc | Obesity | Details |
| NGM-395 | NGM-395 | Phase 1 Clinical | Ngm Biopharmaceuticals Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity | Details |




